Research Professor Akseli Hemminki presents on treatment of human cancer with oncolytic adenoviruses at FIMM

Research Professor Akseli Hemminki presented on October 28, 2010, for a group of oncologists and researchers at Institute for Molecular Medicine Finland (FIMM). His presentation gives an example of delivering a personalized therapy approach with oncolytic adenoviruses. The presentation also discusses the immune response associated with the researched oncolytic agents: both the oncolysis and the presence of adenoviruses in tumors are strong danger signals to the immune system, mediating significant natural immunologic response against the tumor.

Adenovirus Ad-5/3